In vitro and in vivo investigation of antilithiatic and antioxidant activity of aqueous extract of Aerva lanata 42 EXPERIMENTAL PROCEDURE The aim of the study was to investigate the antilithiatic and antioxidant potential of the selected plants. The study was conducted using in vitro and in vivo model systems. The study focused on analyzing the antilithiatic potential of selected medicinal plants. The plants selected for the study were chosen based on their traditional usage for lithiasis. Tribulus terrestris (leaf), Aerva lanata (flower), Scoparia dulcis (leaf), and Tridax procumbens (leaf), were collected from Kalapatti, Coimbatore. The leaf and flower samples were identified and certified by the Botanical Survey of India, Coimbatore (BSI/SRC/5/23/2014-15/Tech/19). The leaves and flowers were washed thoroughly in running tap water in order to remove any dirt or soil particles adhered and blotted gently between folds of tissue paper to remove any water droplets. The samples were shade dried and powdered to fine particles in a blender (Multipurpose domestic mixer grinder). The powered sample was sieved using 0.2mm sieve. The extraction was carried out using solvents of increasing polarity by hot percolation method. The residue was dried and used for further analysis. The study was performed in three distinct phases. In the first phase, the in vitro antilithiatic potential of selected plant extracts was analyzed and the plant with maximum activity was selected. The second phase was formulated to study the in vivo protective effects of the selected plant extracts against ethylene glycol induced crystal formation in the kidneys. In vitro cell based Assays were performed to study the potency of the extract against crystallization. The third phase, focused on an attempt to identify the major active components in the leaves using various spectral techniques. The experimental procedure pertaining to the present study “In vitro and In vivo Investigation of Antilithiatic and Antioxidant Activity of Aqueous Extract of Aerva lanata” are elaborated with the details of the experimental conditions and the steps of the procedures employed to study the various parameter which are presented in this chapter. 3
53
Embed
EXPERIMENTAL PROCEDURE - Shodhgangashodhganga.inflibnet.ac.in/bitstream/10603/73397/3/shrin...Experimental Procedure In vitro and in vivo investigation of antilithiatic and antioxidant
This document is posted to help you gain knowledge. Please leave a comment to let me know what you think about it! Share it to your friends and learn new things together.
Transcript
Experimental Procedure
In vitro and in vivo investigation of antilithiatic and antioxidant activity of aqueous extract of Aerva lanata 42
EXPERIMENTAL PROCEDURE
The aim of the study was to investigate the antilithiatic and antioxidant
potential of the selected plants. The study was conducted using in vitro and in
vivo model systems.
The study focused on analyzing the antilithiatic potential of selected medicinal
plants. The plants selected for the study were chosen based on their traditional usage
for lithiasis. Tribulus terrestris (leaf), Aerva lanata (flower), Scoparia dulcis (leaf), and
Tridax procumbens (leaf), were collected from Kalapatti, Coimbatore. The leaf and
flower samples were identified and certified by the Botanical Survey of India,
Coimbatore (BSI/SRC/5/23/2014-15/Tech/19). The leaves and flowers were washed
thoroughly in running tap water in order to remove any dirt or soil particles adhered
and blotted gently between folds of tissue paper to remove any water droplets.
The samples were shade dried and powdered to fine particles in a blender
(Multipurpose domestic mixer grinder). The powered sample was sieved using 0.2mm
sieve. The extraction was carried out using solvents of increasing polarity by hot
percolation method. The residue was dried and used for further analysis.
The study was performed in three distinct phases. In the first phase, the in
vitro antilithiatic potential of selected plant extracts was analyzed and the plant
with maximum activity was selected. The second phase was formulated to study
the in vivo protective effects of the selected plant extracts against ethylene glycol
induced crystal formation in the kidneys. In vitro cell based Assays were
performed to study the potency of the extract against crystallization. The third
phase, focused on an attempt to identify the major active components in the
leaves using various spectral techniques.
The experimental procedure pertaining to the present study “In vitro and In
vivo Investigation of Antilithiatic and Antioxidant Activity of AqueousExtract of Aerva lanata” are elaborated with the details of the experimental
conditions and the steps of the procedures employed to study the various parameter
which are presented in this chapter.
3
Experimental Procedure
In vitro and in vivo investigation of antilithiatic and antioxidant activity of aqueous extract of Aerva lanata 43
PHASE I
3.1. Solvent extraction
3.2. Assessment of in vitro antilithiatic potential of selected plant extracts
3.2.1. In vitro calcium oxalate assays
3.2.1.1. Nucleation assay
3.2.1.2. Growth assay
3.2.1.3. Aggregation assay
PHASE II
3.3. Assessment of antilithiatic potential of selected plant extract
3.3.1. In vivo analysis in experimental animals
3.3.1.1. Volume of urine and pH
3.3.1.2. Estimation of calcium
3.3.1.3. Estimation of oxalate
3.3.1.4. Estimation of phosphate
3.3.1.5. Estimation of uric acid
3.3.1.6. Estimation of creatinine
3.3.1.7. Estimation of magnesium
3.3.1.8. Estimation of citrate
3.3.1.9. Estimation of calcium and oxalate in kidney homogenate
3.3.1.10. Estimation of alanine aminotransferase (ALT) and aspartate
aminotransferase (AST) in serum, kidney and liver homogenate
3.3.1.11. Histopathological examination of the kidney architecture
Experimental Procedure
In vitro and in vivo investigation of antilithiatic and antioxidant activity of aqueous extract of Aerva lanata 44
3.3.2. In vitro analysis using NRK 52E cell lines
3.3.1. MTT dye reduction assay
3.3.2. Sulphorhodamine B assay
3.3.3. Lactate dehydrogenase assay
3.3.4. Morphological changes of the cells as observed by Giemsa staining
PHASE III
3.4. Assessment of antioxidant potential of selected plant extract
3.4.1. Determination of the activities of enzymic antioxidants
3.4.1.1. Assay of superoxide dismutase
3.4.1.2. Assay of catalase
3.4.1.3. Assay of peroxidase
3.4.1.4. Assay of glutathione reductase
3.4.1.5. Assay of glutathione -S-transferase
3.4.1.6. Assay of polyphenol oxidase
3.4.2. Estimation of the levels of non-enzymic antioxidants
3.4.2.1. Estimation of ascorbic acid (Vitamin C)
3.4.2.2. Estimation of tocopherol (Vitamin E)
3.4.2.3. Estimation of total carotenoids and lycopene
3.4.2.4. Estimation of reduced glutathione (GSH)
3.4.2.5. Estimation of total phenols
3.4.2.6. Estimation of flavonoids
3.5. Assessment of radical scavenging potential
3.5.1. DPPH
3.5.2. ABTS
3.5.3. Hydrogen peroxide
3.5.4. Hydroxyl radical
Experimental Procedure
In vitro and in vivo investigation of antilithiatic and antioxidant activity of aqueous extract of Aerva lanata 45
3.6. Characterization of phytochemical constituents of selected plant extract
3.6.1. Preliminary phytochemical analysis
3.6.2. UV/visible absorption spectrum analysis
3.6.3. HPLC
3.6.4. HPTLC
3.6.5. FT- IR spectrum
3.6.6. GC-MS
3.6.7. TLC
3.6.8. 1H NMR spectrum
3.7. Statistical analysis
Chemicals
All the chemicals used in the present study were of analytical grade.
Experimental Procedure
In vitro and in vivo investigation of antilithiatic and antioxidant activity of aqueous extract of Aerva lanata 46
Plate 1
Tribulus terrestris
Plate 2
Aerva lanata
Experimental Procedure
In vitro and in vivo investigation of antilithiatic and antioxidant activity of aqueous extract of Aerva lanata 47
Plate 3
Scoparia Dulcis
Plate 4
Tridax procumbens
Experimental Procedure
In vitro and in vivo investigation of antilithiatic and antioxidant activity of aqueous extract of Aerva lanata 48
PHASE I
This phase involves the collection of samples and screening of the plant
extracts for its response against the three critical stages of stone formation-
nucleation, growth and aggregation.
3.1. Solvent extraction
In order to understand the bioactive principle present in the plant, the
powdered samples were sieved (0.2mm), packed in a thimble and subjected to
individual extraction using Soxhlet apparatus. Solvents of increasing polarity
namely chloroform, methanol and water were used.
The samples were extracted using hot percolation method. The extraction
was repeated until the plant material becomes colourless. The extract was
evaporated and residue was stored in airtight containers and refrigerated at 4°C.
Preparation of aqueous extract
Aqueous extract of the plant sample also prepared as follows. To 1g of the
powdered sample, added 100mL of distilled water and kept in a water bath at
60°C for 2 h. Filtered using Whatman filter paper and centrifuged thrice at 5,000
rpm for 5mins, and the supernatant was collected, evaporated in a flash
evaporator and stored in an air tight container in the refrigerator at 4°C.
3.2. Assessment of in vitro antilithiatic potential of selected plant extracts
3.2.1. In vitro calcium oxalate assay
The solvent extracts of selected medicinal plants were tested for its
antilithiatic potential in respect of nucleation, growth and aggregation assays.
3.2.1.1. Nucleation assay
The method used was as described by Hennequin et al. (1993) with some
minor modifications.
Experimental Procedure
In vitro and in vivo investigation of antilithiatic and antioxidant activity of aqueous extract of Aerva lanata 49
Principle
The nucleation assay is based on the crystal dissolution per cent,
absorbance increases with increase in the crystal dissolution which is measured
at 620nm spectrophotometrically (Genesys 10-S, USA)
Reagents
1. Tris buffer (0.05M) containing sodium chloride (0.15M), pH 6.5
2. Calcium chloride (3mM)
3. Sodium oxalate (0.5mM)
Procedure
Solutions of calcium chloride and sodium oxalate were filtered thrice
through 0.22µm filter, from which 950µL of calcium chloride was mixed with
100µL of extract at different concentrations (50µg - 3200µg/mL). Crystallization was
initiated by adding 950µL of sodium oxalate solution. The final solution was
magnetically stirred at 800 rpm using a PTFE-coated stirring bar. The temperature
was maintained at 37ºC. The optical density of the solution was monitored at
620nm. The rate of nucleation was estimated by comparing the induction time
(the delay before the appearance of crystals that have reached a critical size and
thus become optically detectable) in the presence of the extract with that of the
control in which corm extract was not added.
3.2.1.2. Growth assay
The extent of calcium oxalate crystal dissolution was assessed by the
protocol described by Chaudhary et al. (2009).
Principle
The rate of crystal growth was determined by the addition of COM crystals
to calcium chloride and sodium oxalate solutions in the presence and absence of
the extracts. The turbidity is measured at 214nm.
Experimental Procedure
In vitro and in vivo investigation of antilithiatic and antioxidant activity of aqueous extract of Aerva lanata 50
Reagents
1. Tris buffer (10mM) containing sodium chloride (10mM), pH 7.2
2. Calcium chloride (4mM)
3. Sodium oxalate (4mM)
4. COM seed preparation (Pak et al., 1975): COM seed crystals were
prepared by mixing equal volumes of 0.01 M calcium chloride and 0.01 M
sodium oxalate by drop wise addition of sodium oxalate solution to
calcium chloride solution, with constant stirring for 72h at 4ºC. The solution
was centrifuged at 2000xg (RCF) for 10min at room temperature.
The crystal pellet was washed with distilled water followed by methanol
and then air dried and was used for further studies.
5. COM slurry preparation: The crystal slurry was prepared by equilibrating
seed crystals in 50mM sodium acetate and adjusts pH at 5.7 by adding
glacial acetic acid. To this COM crystals (1.5mg/mL) were added and used
for growth assay.
Procedure
4mM calcium chloride and 4mM sodium oxalate of 1mL each were added
to a 1.5mL solution containing sodium chloride (10mM) buffered with Tris base
(10mM) at pH 7.2. To this 30μl of COM crystal slurry (1.5mg/mL of 50mM sodium
acetate buffer of pH 5.7) was added. Consumption of oxalate begins immediately
after addition of COM crystal slurry and was monitored for 600 sec for the
disappearance of absorbance at 214nm. When the corm extract was added to this
solution, depletion of free oxalate ions would decrease if the extract inhibited calcium
oxalate crystal growth. Rate of reduction of free oxalate was calculated using the
baseline value and the value after 30 sec incubation with or without the extract. The
relative inhibitory (Ir) activity was calculated as
Experimental Procedure
In vitro and in vivo investigation of antilithiatic and antioxidant activity of aqueous extract of Aerva lanata 51
3.2.1.3. Aggregation assay
The crystals in solution stick together to form large particles called
aggregates and the inhibitory effect in the plant extracts was determined by the
protocol described by Hess et al. (1989).
Principle
The aggregation assay is based on the crystal dissolution per cent as
turbidity increases with increase in the crystal dissolution and measured at
620nm.
Reagents
1. Calcium chloride (50mM)
2. Sodium oxalate (50mM)
3. COM crystal seed preparation: 50mM of calcium chloride and sodium oxalate
were mixed and equilibrated to 60°C in a water bath for one hour, cooled and
left overnight at 37°C. The crystals were harvested by centrifugation and then
completely dried at 37°C.
4. Tris buffer (0.05M) containing sodium chloride (0.15M), pH 6.5
Procedure
COM crystals were used at a final concentration of 0.8mg/mL buffered
with 0.05M Tris containing sodium chloride (0.15M) at pH 6.5. Experiments were
conducted at 37°C in the presence and absence of the corm extract after the
arrest of stirring. The rate of aggregation was estimated as below by comparing
the slope of the turbidity in the presence of the extract and with that obtained in
the control.
Experimental Procedure
In vitro and in vivo investigation of antilithiatic and antioxidant activity of aqueous extract of Aerva lanata 52
PHASE II
To further substantiate the results of the in vitro assays the in vivo
analyses were performed using male Wistar rats. In vitro cell based assays to
represent essential aspects of in vivo pharmacology and toxicology was
performed using NRK 52E cell lines.
3.3. Assessment of antilithiatic potential of Aerva lanata
Animal selection
In urolithiatic study, male rats were selected as a model system to induce
renal stones as the urinary system of male rats resembles that of humans
(Khan, 1997) and males are more prone to kidney stone formation compared to
females. Healthy male Wistar albino rats were obtained from Small Animal
Breeding Station, Mannuthy, Thirssur, Kerala, India. Animals of 8 weeks old
weighing 150-200g were chosen for the study. The animals were acclimatized
for two weeks in polypropylene cages and maintained at 27±2ºC, under 12h
light/dark cycles, provided with rat chow and drinking water ad libitum.
Induction of lithiasis using ethylene glycol
Ethylene glycol is a metabolic precursor of oxalate. The oxalate formation
starts after 24-72h of administration. Treatment groups were fed with ethylene
glycol (0.75%) in drinking water for induction of kidney stones except the control
group of animals.
Induction of lithiasis using ethylene glycol
Ethylene glycol is a metabolic precursor of oxalate. The oxalate formation
stars after 24- 72h of administration. Treatment groups were fed with ethylene
glycol (0.75%) in drinking water for induction of stone formation except control
groups.
Experimental Procedure
In vitro and in vivo investigation of antilithiatic and antioxidant activity of aqueous extract of Aerva lanata 53
Treatment Groups
(5 rats in each group- As instructed by the Institute Animal Ethics Committee)
1. Control (Untreated) - Regular diet and potable water for 28 days
2. Lithiatic control - Ethylene glycol (0.75%) in drinking water for28 days
3. Extract control - Extract of selected plant (1600µg/kg body weight)administration by gavage for 28 days
4. Preventive regimen - Ethylene glycol (0.75%) in drinking water andselected plant extract administration by gavage for28 days
5. Curative regimen - Ethylene glycol (0.75%) water for 1-14 days,followed by selected plant extract administrationfrom 15th to 28th day by gavage
6. Standard drug -(Cystone)
Ethylene glycol (0.75%) water for 1-14 days,followed by Cystone administration from 15th to28th day by gavage
This experimental protocol was approved by the Institute Animal Ethics
Committee (Approval No. AUW.IAEC.2013-14.BT:05). Urine, serum, liver and
kidney homogenates of the control and treatment rats were utilized for the
following biochemical assays.
3.3.1. In vivo analysis in experimental animals
All animals were kept in individual metabolic cages and the urine was
collected on 0, 7th, 14th, 21st and 28th day of the study period. Animals had free
access only to drinking water during urine collection period. The urine was
analyzed for volume, pH, calcium, oxalate, inorganic phosphorus, uric acid and
creatinine.
At the end of the study all the rats were subjected to mild anesthesia
(diethylether) and blood was collected by cardiac puncture. Then the rats were
killed by cervical dislocation and liver and kidneys were dissected out. This was
used for biochemical and histopathological studies.
Experimental Procedure
In vitro and in vivo investigation of antilithiatic and antioxidant activity of aqueous extract of Aerva lanata 54
3.3.1.1. Volume of urine and pH
The volume of urine collected on 0, 7th, 14th, 21st and 28th day was
recorded. The pH of the urine was noted using Systronics digital pH meter.
3.3.1.2. Estimation of calcium
Calcium was estimated in the urine and serum by the method proposed by
Clark and Collip (1985).
Principle
Calcium is precipitated directly from urine and serum as oxalate. The
precipitate was dissolved in acid and titrated against 0.01N Potassium
permanganate.
Reagents
1. 4% Ammonium oxalate
2. 2% Ammonia
3. 0.1N Sulphuric acid
4. 0.01N Potassium permanganate
Procedure
To 2.0mL of the urine, 2.0mL of water and 1.0mL of 4% ammonium
oxalate was added and allowed to stand overnight. The precipitated calcium
oxalate was centrifuged. The supernatant was removed without disturbing the
precipitate and 3.0mL of 2% ammonia was added down of the tube, mixed with
the precipitate and centrifuged. This was repeated till the supernatant gave no
precipitate with calcium chloride. This was done to remove excess of ammonium
oxalate. Finally 2.0mL of 0.1N Sulphuric acid was added and mixed well until the
precipitate was dissolved. This was warmed by placing in a beaker containing
boiling water to complete the dissolution of oxalate. Then it was titrated against
0.01N potassium permanganate while keeping the mixture at 70-75ºC to a faint pink
colour which persisted for about one min. A blank was titrated with 2.0mL of 0.1N
Experimental Procedure
In vitro and in vivo investigation of antilithiatic and antioxidant activity of aqueous extract of Aerva lanata 55
sulphuric acid to same end point and the difference between the two titre values
gave the volume of 0.01N Potassium permanganate required to titrate calcium
oxalate precipitate (1mL of 0.01N KMnO4 is equivalent to 0.2mg of calcium).
3.3.1.3. Estimation of oxalate
Oxalate was estimated in the urine by the method proposed by
Hodgkinson and Williams (1972).
Reagents
1. Electrolyte Zinc: Electrolyte zinc wire (3mm dia) was cut into the short
length measuring approximately 5mm and approximately 250mg was
weighed. Immediately before use, the zinc was cleaned by immersing
briefly in a freshly prepared 10N HNO3 (two volumes of concentrated
HNO3 to one volume of water) and washed thoroughly in distilled water.
2. Chromotropic acid solution: 1g of 4, 5, dihydroxynapthalene 2,
7-disulphonic acid and disodium salt “for formaldehyde determination” was
dissolved in 100mL of distilled water and stored at 4°C.
3. Oxalic acid standard: 1.023g of potassium oxalate monohydrate was
dissolved in 100mL of distilled water and stored at 4°C. This solution
contained 5mg of anhydrous oxalic acid per mL.
Procedure
Urine sample was acidified by the addition of Concentrated HCl (1mL per
100mL of the urine) to ensure any crystals of calcium oxalate which may be
present were dissolved in the solution. 0.5mL of the urine was transferred into
25mL of graduated stoppered centrifuge tube followed by 1.5mL of water and a
drop of 0.04% bromo-thymol blue indicator solution. pH was adjusted to 7 by the
addition of 0.1N diluted sodium hydroxide or diluted acetic acid solution.
Experimental Procedure
In vitro and in vivo investigation of antilithiatic and antioxidant activity of aqueous extract of Aerva lanata 56
Then 2mL of the saturated aqueous calcium sulphate solution was added
followed by 14mL of ethanol and the contents were mixed gently and allowed to
stand at room temperature overnight.
This solution was centrifuged at 2000rpm for 3min. The supernatant fluid
was carefully poured off and the tube was allowed to drain for a few min on a
filter paper. Mouth of the tube was wiped with clean tissue and the precipitate
was dissolved in 5ml 2N H2SO4 solution. A piece of the freshly cleaned zinc was
added and heated in a boiling water bath for 30 min (the tubes were left without
stoppered to allow evaporation to final volume less than 0.5mL)
The zinc was moved to the mouth of the tube with a bent glass rod and
washed with 0.5mL of 1% chromotropic. This operation was most conveniently
carried out by fixing the tube almost horizontally in a report clamp to allow
washing the piece of zinc.
Concentrated H2SO4 was added slowly while mixing and heating in a
boiling water bath for 30 min. (The tubes need not be stoppered). Then the tubes
were cooled and diluted to 20mL with 10N H2SO4 and the optical density was
measured at 540nm. The developed colour was stable for several hours.
Stock standard oxalic acid solution was diluted 100 times (50µg of oxalic
acid per mL). Six tubes containing 0, 0.2, 0.4, 0.6, 0.8, and 1mL of diluted
standard oxalic acid solution (corresponding to 0, 10, 20, 30, 40, and 50µg of
anhydrous oxalic acid respectively) were prepared along with a blank. Water was
added to make the final volume of the reaction mixture to 1mL, followed by 1mL
of 4N H2SO4 and a piece of freshly cleaned zinc and then proceeded as
described in procedure.
The concentration of oxalic acid in the original sample of urine was given
by the equation:
Experimental Procedure
In vitro and in vivo investigation of antilithiatic and antioxidant activity of aqueous extract of Aerva lanata 57
3.3.1.4. Estimation of phosphate
The amount of inorganic phosphate present in urine and serum was
determined by the Fiske and Subbarow method (1925).
Principle
Phosphorus reacts with molybdic acid to form phosphomolybdic acid and
the digested solution is treated with ammonium molybdate and 1,2,4 amino
naphthol sulphonic acid. It is selectively reduced to produce a deep blue colour
(molybdenum blue) which is probably a mixture of lower oxides of molybdenum.
The blue colour developed is then compared with the standard treated in the
similar manner in a colorimeter at 660nm.
Reagents
1. 10N Sulphuric acid
2. Ammonium molybdate I: 25g of analytical grade ammonium molybdate
was dissolved in 200mL of distilled water and transferred to one litre
volumetric flask containing 500mL of 10N sulphuric acid and then the
volume was made up to the mark with water and mixed well.
3. Ammonium molybdate II: Dissolved 25g of ammonium molybdate in
200mL of distilled water and transferred to one litre volumetric flask
containing 300mL of 10N sulphuric acid and then made up to the mark
with water and mixed.
4. 1,2,4 amino napthol sulphonic acid (ANSA): Into a glass stoppered
cylinder 195mL of 15% sodium bisulphite solution, 0.5g of 1,2,4 amino
napthol sulphonic acid and 5mL of 20% sodium sulphate were added and
shaken well until the powder was dissolved. The solution was transferred
to a bottle and stored under refrigerated condition.
5. Stock standard phosphate solution: To 35.1mg of potassium dihydrogen
phosphate in water, 1.0mL of 10N sulphuric acid was added and diluted to
100mL with water and mixed well.
Experimental Procedure
In vitro and in vivo investigation of antilithiatic and antioxidant activity of aqueous extract of Aerva lanata 58
6. Working standard solution: 10mL of stock standard phosphate was diluted
to 100mL. One mL of the solution contains 8µg of phosphorus.
Procedure
Into a series of test tubes, 8, 16, 24, 32 and 40μg concentration of
standard phosphorous solution was pipetted out. To this one mL of molybdate I
solution and 0.4mL of ANSA reagent were added and the volume was made up
to 10mL with water. The urine was also treated in a similar way except for the
addition of molybdate II, 25μl of urine mixed with 975μl of water and treated as
above. The colour developed after 20 min was read in a colorimeter using red
filter against a reagent blank at 660nm. Concentration of phosphorus present in
the sample solution was calculated by plotting the concentration of phosphorus
on X-axis and the colorimeter reading on Y-axis. From the standard graph, the
amount of phosphorus present in the urine was calculated.
3.3.1.5. Estimation of uric acid
The amount of uric acid present in the given sample was estimated by the
method of Caraway (1955).
Principle
Uric acid reduces sodium phosphotungstate in alkaline medium to give a
blue colour which is measured colorimetrically at 640nm.
Reagents
1. 14% Sodium carbonate solution
2. Uric acid reagent: To 50g of sodium tungstate in 400mL of water, added 40mL
of 85% phosphoric acid and refluxed gently for 2h. Cooled, transferred to
500mL flask and made up to mark with distilled water. Diluted 1:10 before use.
3. Stock standard uric acid: To 100mg of uric acid with 60mg of lithium
carbonate, added 15mL of water. Heated the solution above 60ºC and
poured into 100mL standard flask. Made up to the mark with distilled water.
Experimental Procedure
In vitro and in vivo investigation of antilithiatic and antioxidant activity of aqueous extract of Aerva lanata 59
4. Working standard: Diluted 2.0mL of the stock to 100mL with water. This
solution contains 20µg of uric acid per mL.
Procedure
To 30μl of urine, added 2.97mL of distilled water. Into different tubes
pipetted out 0.5-2.5mL of the working standard, corresponding to 10, 20, 30, 40,
and 50µg of uric acid respectively and made up to 3mL, and water served as
blank.
In a separate test tube with 8mL of water, added 1mL of serum, 0.6mL of
10% sodium tungstate and 0.5mL of 0.67 N sulphuric acid. Shook well and
centrifuged after 15 min. 3mL of the supernatant was taken for the experiment.
To all the tubes added 1mL of uric acid reagent followed by 1mL of 14% sodium
carbonate and allowed to stand for 25 min for the colour to develop. This was
read in a colorimeter at 640nm against a reagent blank.
3.3.1.6. Estimation of creatinine
The amount of creatinine present in urine and serum was estimated by the
method of Bones and Taussky (1945).
Principle
The method makes use of the Jaffe’s reaction, the production of a
mahogany red colour with an alkaline picrate solution. The intensity of the colour
developed is compared in a colorimeter against a reagent blank at 540nm.
Reagents
1. 0.04M Picric acid
2. 0.75N Sodium hydroxide
3. Stock solution of creatinine - 100mg of creatinine was dissolved in 0.1N
hydrochloric acid and the volume made up to 100mL.
4. Working standard – One mL of stock solution dissolved in 50mL of water.
This contains 20µg of creatinine per mL.
Experimental Procedure
In vitro and in vivo investigation of antilithiatic and antioxidant activity of aqueous extract of Aerva lanata 60
Procedure
Tubes containing 0.5, 1.0, 1.5, 2.0, 2.5 and 3.0mL of the working standard
solutions corresponding to 10, 20, 30, 40, 50 and 60µg of creatinine were taken.
The volume was made up to 3mL with water in all the tubes. 3.0mL of water was
taken as blank. One mL of the urine sample was made up to 100mL with distilled
water. From this 3mL was taken for the experiment.
For serum creatinine, 3mL of water was added to 2.0mL of serum, 1.0mL
of 10% sodium tungstate solution and 2.0mL of 0.67N sulphuric acid and kept for
10 min and centrifuged. 3mL of the supernatant was pipetted out in a test tube.
Along with these, a blank was also prepared.
To all the tubes namely the blank, standard, urine and serum tubes, added
1mL of 0.04M picric acid solution and 1mL of 0.75N sodium hydroxide were
added and allowed to stand for 20 min for the colour to develop. The tubes were
shaken well and the colour so developed was read in a colorimeter at 500nm
against the reagent blank.
3.3.1.7. Estimation of magnesium
The amount of magnesium present in urine was estimated by the method
of Kolthoff (1927) as described by Sky-Peck (1964).
Principle
The dye, thiazole yellow (methylbenzothiazole- [1,3]- 4,4’-
diazoaminobenzol -2,2’- disulfonic acid), combined with magnesium hydroxide in
alkaline solution to form a red lake, the intensity of which was proportional to tile
magnesium concentration.
Reagents
1. Trichloroacetic acid, 5 and 10 % (w/v)
2. Polyvinyl alcohol, 0.015% (w/v) – Reagent was dissolved by gently
warming in water bath and thymol crystals were added as a preservative.
Experimental Procedure
In vitro and in vivo investigation of antilithiatic and antioxidant activity of aqueous extract of Aerva lanata 61
3. Thiazole yellow, 0.0035% (w/v) in 0.015% polyvinyl alcohol. This reagent
is light sensitive, and should be stored in brown bottle.
4. Magnesium standard solution (5mg/mL) – In one litre of distilled water
50.67mg of MgSO4.7H2O was added.
5. 2N lithium hydroxide – To 83.92g of LiOH.H2O, one litre of distilled water
was added and stored in a plastic bottle.
Procedure
One mL aliquot from a well-mixed 24h urine sample was added to 50mL
volumetric flask and diluted to the mark with distilled water. To 2mL of aliquot of
diluted urine sample, 1mL of 0.0035% thiazole yellow reagent, followed by 1mL of
2N LiOH were added and mixed thoroughly by inversion. The standard was
prepared by adding 1mL of 10% TCA to 1mL of the magnesium standard, followed
in sequence by 1mL of 0.0035% thiazole yellow reagent and 1mL of 2N LiOH.
Blank was prepared by using 1mL of distilled water in place of the standard. All
samples were allowed to stand at least for 15 min before reading at 540nm.
The concentration of Mg in urine was calculated using
3.3.1.8. Estimation of citrate
The amount of citrate present in urine was determined by the method of
Millan et al. (1987) with a subsequent modification of Levis (1990).
Principle
In alkaline pH, phosphates in the urine were precipitated by magnesium
chloride and citrate forms a yellow coloured complex which can be monitored
spectrophotometrically at 390 nm.
Experimental Procedure
In vitro and in vivo investigation of antilithiatic and antioxidant activity of aqueous extract of Aerva lanata 62
Reagents
1. 25% Ammonium hydroxide solution.
2. 0.2M Magnesium chloride solution
3. 10M HCl solution
4. Citric acid trisodium salt was used as standard.
5. 18mM Ferric chloride solution was prepared freshly, in deionized water
instead of HCl solution.
Procedure
To 0.1mL of ammonium hydroxide (25%), 4mL of sample was added and
was mixed well by vortex. To this 0.9mL of magnesium chloride solution was
added and mixed on a vortex mixer and the mixture was centrifuged at 4000xg
(RCF) for 10 min to obtain phosphate-free urine. The supernatant was then
transferred to clear tubes. After adjusting pH of the supernatant to 2 with 0.1mL
of 10M HCl, the supernatant was again mixed by vortex. To the mixture 0.25mL
of ferric chloride (18mM) was added and mixed on a vortex mixer and
absorbance was immediately read against the deionized water at 390nm.
Reagent blank was prepared with the addition of 0.25mL of ferric chloride
to 4.75mL HCl solution and read against the deionized water. Test sample was
prepared with the addition of 0.75mL of urine sample to 4.25mL of HCl solution
and read against the deionized water. Five solutions of citrate (0.312, 0.625, and
1.25, 2.5 and 5.0 mM) were prepared in deionized water and used as standards.
3.3.1.9. Estimation of calcium and oxalate in kidney homogenate
Kidney homogenate were made in 2N HCl by grinding in mortar and
pestle. The sample contained equivalent of 100mg of dry weight of kidney in
10mL of hydrochloric acid (Khan et al., 2001). The homogenate was heated in
water bath at 70ºC for one hour. The solution was later centrifuged at the rate of
2000 rpm for 10 min and calcium was determined in the supernatant as
described earlier by the method proposed by Clark and Collip (1985).
Experimental Procedure
In vitro and in vivo investigation of antilithiatic and antioxidant activity of aqueous extract of Aerva lanata 63
Oxalate was precipitated by adding 1M calcium chloride solution and left
overnight at 4ºC. The oxalate was then determined by titration with 0.02N
KMnO4 while solution was kept at 90ºC. The end point was appearance of pale
pink colour which persists for 30 seconds.
3.3.1.10. Estimation of alanine aminotransferase (ALT) and aspartateaminotransferase (AST) in serum, kidney and liver homogenate
Kidney and liver was cut into small pieces on ice and homogenized using
mortar and pestle with 10% Tris HCl buffer (0.1M, pH 7.4). The homogenate was
centrifuged at 10,000 rpm at 4°C and the supernatant was collected for the
estimation of ALT and AST as described by Reitman and Frankel (1957), using
Cogent ALT and AST test Kit.
i) Alanine aminotransferase assay
Principle
Alanine aminotransferase catalyzes the transamination of L-Alanine and
α-ketoglutarate (α-KG) to form pyruvate and L-glutamate. Pyruvate so formed is
coupled with 2,4-dinitrophenyl hydrazine (2,4-DNPH) to form a corresponding
hydrazine, a brown coloured complex in alkaline medium and this can be measured
colorimetrically (Genesys 10-S, USA).
Reagents
1. Buffered alanine-α-KG, pH 7.4.
2. 2,4-DNPH colour reagent
3. 4N Sodium hydroxide: One mL was diluted to 10mL with distilled water.
4. Working standard: Pyruvate 8mM (150 IU/L).
Procedure
Buffered alanine- α – KG 0.25mL was pipetted out in all the tubes labelled
as blank, standard, sample and to control. To the standard tube 0.05mL of
standard was pipetted out and to sample tube 0.05mL of kidney or liver
homogenate were added, mixed well and incubated at 37ºC for 30 min. To all the
Experimental Procedure
In vitro and in vivo investigation of antilithiatic and antioxidant activity of aqueous extract of Aerva lanata 64
tubes added 0.25mL of 2,4-DNPH colour reagent was added. To the blank tube
0.05mL of distilled water was added. They were mixed well and allowed to stand at
room temperature (25- 30ºC) for 20 min. At the end of 20 min of incubation 2.5mL
of diluted sodium hydroxide was added, mixed well and the O.D. was read
against distilled water in a colorimeter using green filter (505nm) within 15 min.
ii) Aspartate aminotransferase assay
Principle
Alanine aminotransferase catalyses the transamination of L-Aspartate and
(α - KG) to form oxaloacetate and L-Glutamate. Oxaloacetate so formed is coupled
with (2,4-DNPH) to form a corresponding hydrazine, a brown coloured complex in
alkaline medium and this can be measured colorimetrically (Genesys 10-S, USA).
Reagents
1. Buffered alanine-α-KG, pH 7.4
2. 2,4-DNPH colour reagent
3. 4N Sodium hydroxide: Diluted 1.0mL to 10mL with distilled water
4. Working standard: Pyruvate 6mM (114 IU/L)
Procedure
Pipetted out 0.25mL of buffered alanine- α – KG in all the tubes labelled as
blank, standard, sample and to control. To the standard tube pipetted out 0.05mL of
standard and to sample tube added 0.05mL of kidney or liver homogenate. Mixed
well and incubated at 37ºC for 30 min. To all the tubes added 0.25mL of 2,4-DNPH
colour reagent. To the blank tube added 0.05mL of distilled water. Mixed well and
allowed to stand at room temperature (25- 30ºC) for 20 min. At the end of 20 min
incubation added 2.5mL of diluted sodium hydroxide. Mixed well and read the O.D.
against distilled water in colorimeter using green filter (505nm) within 15 min.
Experimental Procedure
In vitro and in vivo investigation of antilithiatic and antioxidant activity of aqueous extract of Aerva lanata 65
3.3.1.11. Histopathological examination of the kidney architecture
The response of the kidney tissue to lithiatic stress and treatment with
the selected plant extract, the tissues were examined for histopathological
changes like the necrosis, edema, and changes in nephron, collecting system
and peritubular interstitium. The Procedure of Luna (1968) was followed for
this study.
Tissue processing
The tissues were placed in 10% formal saline (10% formalin in 0.9%
NaCl) for one hour to rectify shrinkage due to higher concentration of formalin.
They were then left overnight in running water after securing the mouths of the
vessels with cotton gauze. The tissues were dehydrated in ascending grades
of isopropanol by immersing in 80% isopropanol overnight followed by 100%
isopropanol for one hour. The dehydrated tissues were cleared in two changes
of xylene, one hour each. Then the tissues were impregnated with histology
grade paraffin wax at 60ºC. The wax impregnated tissues were embedded in
paraffin blocks using the same grade wax. The paraffin blocks were mounted
and cut with rotary microtome at 3 micron thickness. The sections were
flattened on a tissue flatation bath at 40ºC and taken on a glass slide smeared
with equal parts of egg albumin and glycerol. The sections were then melted in
an incubator at 60ºC and, after 5 min they were allowed to cool.
Tissue staining
The sections were deparaffinised by immersing in xylene for 10 minutes
in a staining jar. The deparaffinised sections were washed in 100%
isopropanol and stained in Ehrlich’s hematoxylin for 8 minutes. After staining
in hematoxylin, the sections were washed in tap water and dipped in acid
alcohol (8.3% HCl in 70%alcohol) to remove excess stain. The sections were
then placed in running tap water for 10 minutes. The sections were counter-
stained in 1% aqueous solution of eosin, for 1 minute. The excess stain was
washed in tap water and the sections were allowed to dry. Complete
dehydration of the stained sections were ensured by placing the sections in
Experimental Procedure
In vitro and in vivo investigation of antilithiatic and antioxidant activity of aqueous extract of Aerva lanata 66
the incubator at 60ºC for 4 minutes. When the sections were cooled, they were
mounted in DPX mountant. The cell architecture in the liver was observed
under high power objective in a microscope.
In order to minimize the use of animals for research purpose, with a
focus to reduce animal sufferings, alternative models were used. The use of
alternative experimental systems for studying the antilithiatic property of
extracts of selected plant has been standardized, thereby minimizing the use
of live animals in future research of lithiasis. This approach is part of a global
effort, wherein several alternative systems to replace live experimental
animals are being characterized. Towards this purpose the Normal rat kidney
cell lines (NRK 52E) were procured from National Centre for Cell Science,
Pune, India, and utilized for the study.
3.3.2. In vitro analysis using NRK 52E cell lines
The cells were maintained in CO2 incubator with 5% CO2 and 95%
humidity, supplemented with Dulbecco’s Modified Eagles Medium (DMEM) and
10% Fetal Calf Serum (FCS). Penicillin and streptomycin was also added to the
medium to 1X final concentration from a 100X stock. Once the cells had attained
confluent growth, the cells were trypsinized using Trypsin - EDTA and the
number of cells needed for carrying out various assays were seeded into sterile
6-well and 96 well plates. In each well of the 6-well plates, a clean, dry, sterile
coverslip was placed before the cells were seeded. Then the plates were
incubated in a CO2 incubator with 5% CO2 and 95% humidity atmosphere. COM
crystals at a concentration of 67μg/cm2 (or 0.5mM Oxalate can also be used)
was used as lithiatic agent (COM crystals prepared as explained earlier).
The concentration of plant extract used was 1600µg. The cells were
treated with the oxalate, both in the presence and the absence of the plant
extracts. The exposure of COM crystals were given for 72h at 37ºC. After
treatment, the coverslips from the 6-well plates were removed and placed on a
glass slide and sealed with vaseline. These slides were used for various staining
Experimental Procedure
In vitro and in vivo investigation of antilithiatic and antioxidant activity of aqueous extract of Aerva lanata 67
techniques, whereas in 96-well plates, the medium was removed and replaced
with fresh medium. These were used for checking the viability of cells by MTT
and SRB assays and cell cytotoxicity by LDH assay as described below.
3.3.1. MTT dye reduction Procedure
The MTT [3-(4, 5-dimethyl-thiazol-2-yl)-2, 5-diphenyltetrazolium bromide]
reduction assay as described by Igarashi and Miyazawa (2001) was employed to
elucidate the cytotoxicity of the sample.
Principle
Living cells convert MTT into its formazon derivative. The number of
surviving cells can be determined by the amount of MTT formazon produced,
which is measured in a microtitre plate reader after solubilization with a suitable
solvent.
Reagents
1. PBS (phosphate buffered saline)
2. MTT – 3mg/mL in PBS
3. Isopropanol in 0.04N HCl (acid-propanol)
4. HCl (0.04N)
Procedure
After the incubation period, the medium was removed. The treated cells
(100μl) were incubated with 50μl of MTT at 37ºC for 3 h with mild shaking.
At the end of the incubation period, 200μl of PBS was added to all the samples
and the liquid was carefully aspirated. Acid-propanol (200μl) was added and left
overnight in dark. The absorbance was read at 650nm in a microtitre plate
reader (Anthos 2020, Austria). The optical density of the oxidant-induced cells
were fixed as 100% viabile and the per cent viability of the cells in the other
treatment groups were calculated relative to this.
Experimental Procedure
In vitro and in vivo investigation of antilithiatic and antioxidant activity of aqueous extract of Aerva lanata 68
3.3.2. Sulphorhodamine B assay
The sulphorhodamine B (SRB) assay explained by Skehan et al. (1990)
was employed to determine the cell viability in the presence and the absence of
corm extracts in the oxidant-treated cells.
Principle
SRB is a pink coloured aminoxanthane dye with two sulphonic groups.
Under mildly acidic conditions, SRB binds to basic amino acids in the proteins in
TCA fixed cells to provide a sensitive index of cellular protein content, which is
directly proportional to cell viability.
Reagents
1. TCA (40%)
2. TCA (1%)
3. SRB (0.4% in 1% TCA)
4. Acetic acid (1%)
5. Tris (10mM, pH 10.5)
6. PBS
Procedure
After the treatment, the medium was completely removed from each well
and washed with 200μl PBS to remove the traces of medium and serum. Ice-cold
40% TCA (350μl) was layered on top of the cells and incubated at 4ºC for one
hour, after which the pellet was collected and washed 5 times with cold PBS
(200μl). SRB stain (350μl) was added to each well and left in contact with the cells
for 30 min at room temperature, after which they were washed 4 times with 350μl
of 1% acetic acid to remove any unbound dye. Then, 350μl of 10mM Tris was
added to solubilize the protein-bound dye and was shaken gently for 20 min on a
gyratory shaker. The Tris layer in each well was transferred to a new 96-well plate
and the absorbance was read in a microtitre plate reader (Anthos 2020, Austria)
Experimental Procedure
In vitro and in vivo investigation of antilithiatic and antioxidant activity of aqueous extract of Aerva lanata 69
at 496nm. The optical density of the oxidant-induced cells was fixed as 100%
viabile and the per cent viability of the cells in the other treatment groups were
calculated relative to this.
3.3.3. Lactate dehydrogenase assay
Principle
The target cells are incubated with a cytotoxic agent. During this period,
cytoplasmic lactate dehydrogenase (LDH) is released into the medium due to
plasma-membrane damage. The LDH activity in the supernatant after pelleting
down the cells was measured by a substrate reaction and quantitated with an
ELISA plate reader.
LDH was measured using commercial kits according to the manufacturer’s
directions (Sigma-Aldrich).
3.3.4. Morphological changes of the cells as observed by Giemsa staining
The morphological changes of the cells were followed in the presence and
absence of corm extract and/or oxalate. The treated cells were stained with
Giemsa stain and the morphological changes were viewed under Phase Contrast
microscope (Nikon, Japan) as explained by Chih et al. (2001).
Principle
During cell injury or damage, the cells undergo a series of well-
documented morphological changes, which can be observed after staining with
Giemsa stain.
Reagents
1. PBS, pH 7.4
2. Liquid Giemsa stain (1:2 dilution in PBS)
Procedure
The diluted Giemsa stain (10μl) was added to the treated cells and the
stain was spread by placing a coverslip over it. The cells were observed and
photographed under a Phase Contrast microscope (Nikon, Japan) at 400x
magnification.
Experimental Procedure
In vitro and in vivo investigation of antilithiatic and antioxidant activity of aqueous extract of Aerva lanata 70
PHASE III
Our next objective was to focus on the enzymic and non-enzymic status of
the selected medicinal plant and also it became essential to continue the study to
identify the chemical nature of the active component rendering the biochemical
activity. Hence, the final phase of the study was formulated to identify the
antioxidant status and the active principle(s) rendering the responses evoked by
the extract against stone formation.
Natural antioxidants are studied extensively for their capacity to protect
organisms and cells from damage induced by oxidative stress (Koksal, 2011).
Keeping this in mind, phase III was involved for assessing the antioxidant
status of the selected plant sample. Both enzymic and non-enzymic
antioxidants were analyzed. The methodology adopted for analyzing these
parameters are given below.
3.4. Assessment of antioxidant potential of selected plant extract
The selected plant extract was tested for the activities of enzymic